IBM opens drug discovery database to the NIH

12/13/2011 | Pharmaceutical Business Review Online · iHealthBeat

IBM will open its database of about 2.4 million chemical compounds to the NIH for research. AstraZeneca, Bristol-Myers Squibb, DuPont and Pfizer collaborated with IBM to compile the database based on millions of patent filings and journal abstracts published between 1976 and 2000.

View Full Article in:

Pharmaceutical Business Review Online · iHealthBeat

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ